Lumakras Sales A Highlight Of Amgen’s Mixed Q3

Aimovig Down Sequentially And Year-Over-Year

Nov 03 2021

• By Mandy Jackson

Amgen saw improved Prolia sales but Aimovig underperformed • Source: Alamy

More from New Products

More from Scrip